Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Q4 2022 Earnings Call Transcript March 31, 2023
Operator: Greetings and welcome to the Processa Pharmaceuticals Year-End 2022 Earnings Call and Corporate Update. As a reminder, this call is being recorded. It is now my pleasure to introduce Jim Stanker, Chief Financial Officer. Thank you, sir. You may begin.
Jim Stanker: Thank you, and welcome to Processa’s 2022 year-end results and corporate update conference call. Joining me on the call today is...
